MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$660,601
Net Income
-$929,695
Net Profit Margin
-140.73%
EPS
-$0.41
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
660,601
806,923
766,296
1,026,957
Research and development
552,013
661,443
773,416
756,482
General and administrative
1,080,278
647,597
615,907
815,209
Total operating costs and expenses
1,632,291
1,309,040
1,389,323
1,571,691
Loss from operations
-971,690
-502,117
-623,027
-544,734
Other (expense) income
-72
-21
159
4,011
Interest income, net
42,067
45,756
43,792
30,783
Total other income
41,995
45,735
43,951
34,794
Net loss
-929,695
-456,382
-579,076
-509,940
Basic EPS
-0.41
-0.2
-0.266
-0.33
Diluted EPS
-0.41
-0.2
-0.266
-0.33
Basic Average Shares
2,294,364
2,291,056
2,179,867
1,542,139
Diluted Average Shares
2,294,364
2,291,056
2,179,867
1,542,139
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
XBIO Income Statement Sankey Diagram
Sankey diagram visualizing XBIO income statement for the period
Interest income, net
$42,067
(22.89%↑ Y/Y)
Net loss
-$929,695
(-34.99%↓ Y/Y)
Total other income
$41,995
(17.60%↑ Y/Y)
Other (expense)
income
-$72
(-104.87%↓ Y/Y)
Loss from operations
-$971,690
(-34.13%↓ Y/Y)
Total revenue
$660,601
(11.99%↑ Y/Y)
Total operating costs
and expenses
$1,632,291
(24.19%↑ Y/Y)
General and
administrative
$1,080,278
(64.24%↑ Y/Y)
Research and development
$552,013
(-15.92%↓ Y/Y)
Buy us a coffee
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)